Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2016 | 2014
Number of items: 3.

2022

Breitschwerdt, Sven ORCID: 0000-0001-6585-1605, Schwarze-Zander, Carolynne, Al Tayy, Ahmad, Mutevelli, Julia, Wasmuth, Jan-Christian, Rockstroh, Jurgen K. and Boesecke, Christoph (2022). Implementation of EACS vaccination recommendations among people living with HIV. Infection, 50 (6). S. 1491 - 1498. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

2016

Pett, Sarah Lilian, Amin, Janaki ORCID: 0000-0003-2161-9366, Horban, Andrejz, Andrade-Villanueva, Jaime, Losso, Marcelo, Porteiro, Norma, Sierra Madero, Juan, Belloso, Waldo, Tu, Elise, Silk, David, Kelleher, Anthony ORCID: 0000-0002-0009-3337, Harrigan, Richard, Clark, Andrew, Sugiura, Wataru, Wolff, Marcelo ORCID: 0000-0002-9956-8872, Gill, John, Gatell, Jose, Fisher, Martin, Clarke, Amanda, Ruxrungtham, Kiat, Prazuck, Thierry, Kaiser, Rolf, Woolley, Ian, Alberto Arnaiz, Juan, Cooper, David, Rockstroh, Jurgen K., Mallon, Patrick and Emery, Sean ORCID: 0000-0001-6072-8309 (2016). Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study. Clin. Infect. Dis., 63 (1). S. 122 - 133. CARY: OXFORD UNIV PRESS INC. ISSN 1537-6591

2014

Pollard, Richard B., Rockstroh, Jurgen K., Pantaleo, Giuseppe, Asmuth, David M., Peters, Barry, Lazzarin, Adriano, Garcia, Felipe, Ellefsen, Kim, Podzamczer, Daniel, van Lunzen, Jan, Arasteh, Keikawus, Schuermann, Dirk, Clotet, Bonaventura, Hardy, W. David, Mitsuyasu, Ronald, Moyle, Graeme, Plettenberg, Andreas, Fisher, Martin, Fatkenheuer, Gerd, Fischl, Margaret, Taiwo, Babafemi, Baksaas, Ingebjorg, Jolliffe, Darren, Persson, Stefan, Jelmert, Oyvind, Hovden, Arnt-Ove, Sommerfelt, Maja A., Wendel-Hansen, Vidar and Sorensen, Birger (2014). Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis., 14 (4). S. 291 - 301. OXFORD: ELSEVIER SCI LTD. ISSN 1474-4457

This list was generated on Fri May 3 09:05:44 2024 CEST.